Cholesterol

nitric oxide synthase 3 ; Homo sapiens







26 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32564765 The Influence of Endothelial Nitric Oxide Synthase (eNOS) Genetic Polymorphisms on Cholesterol Blood Levels Among Type 2 Diabetic Patients on Atorvastatin Therapy. 2021 3
2 29372262 Vascular endothelium dysfunction: a conservative target in metabolic disorders. 2018 May 1
3 28138348 Cholesterol Enrichment Impairs Capacitative Calcium Entry, eNOS Phosphorylation & Shear Stress-Induced NO Production. 2017 Feb 3
4 28831159 Phospholipase D2 loss results in increased blood pressure via inhibition of the endothelial nitric oxide synthase pathway. 2017 Aug 22 1
5 25557764 Aspirin may influence cellular energy status. 2015 Feb 15 1
6 26409042 Caveolin-1 scaffolding domain residue phenylalanine 92 modulates Akt signaling. 2015 Nov 5 1
7 24577926 Association of endothelial nitric oxide synthase (eNOS) gene polymorphism (Glu 298 Asp) with coronary artery disease in subjects from Multan, Pakistan. 2014 Mar 1
8 24996290 Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment. 2014 Oct 2
9 23269619 Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease. 2013 Apr 1
10 23517789 Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension. 2013 Jan-Mar 1
11 22063270 Endoplasmic reticulum stress-mediated inhibition of NSMase2 elevates plasma membrane cholesterol and attenuates NO production in endothelial cells. 2012 Feb 1
12 21956531 Influence of eNOS gene polymorphism on cardiometabolic parameters in response to physical training in postmenopausal women. 2011 Sep 1
13 18230825 The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. 2008 Feb 2
14 18550157 Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers. 2008 Aug 3
15 17110473 Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. 2007 Jan 1
16 17126309 AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. 2007 Feb 2
17 15916766 Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. 2006 Jan 1
18 16814758 The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. 2006 Aug 1 1
19 11986889 Effects of LDL cholesterol on vascular function. 2002 Mar 1
20 11136695 Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. 2001 Jan 2 2
21 11348878 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation. 2001 May 1
22 11350569 Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. 2001 May 1
23 11673056 Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease. 2001 Aug 1
24 11707586 Distinction between signaling mechanisms in lipid rafts vs. caveolae. 2001 Nov 20 2
25 10542298 Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. 1999 Nov 5 1
26 10568338 Cholesterol-dependent regulation of nitric oxide production: potential role in atherosclerosis. 1999 Sep 3